Article
The development of pharmacogenomic models to predict drug response.
Current opinion in drug discovery & development - 1 May 2001
Adam G I
Abstract excerpt
The potential of pharmacogenomic research to improve general healthcare, reduce morbidity and mortality resulting from treatment side effects, and to accelerate therapeutic compound discovery, design and development in the pharmaceutical industry, remains largely unfulfilled. Major contributory factors affecting progress in the field include: (i) the need for large clinical populations and control/placebo-treated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.